Vertex Pharmaceuticals falls after Q4 profit miss

Vertex Pharmaceuticals

12/02/2026 21:47

** Shares of Vertex Pharmaceuticals VRTX.O fall 1.1% to $460.07 in after-market trading

** Co reports Q4 adj. profit of $5.03 per share, lower than estimates of $5.07 per share, as per LSEG data

** Forecasts 2026 revenue to be in the range of $12.95 billion to $13.1 billion, the midpoint of which is in line with analysts' estimates of $13.02 billion

 ** Reports Q4 revenue of $3.19 billion, compared with analysts' estimates of $3.18 billion

** VRTX was up 12.6% in 2025

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com))